Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2022 | Potential of immunotherapy for kidney cancer

Hyung Kim • 18 Feb 2022
GU Cancers 2022
Genitourinary Cancer Kidney Cancer

Hyung Kim, MD, Cedars-Sinai Medical Center, Los Angeles, CA, discusses how useful immunotherapy is for the treatment of kidney cancer, especially in the adjuvant setting. This interview took place at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2022 in San Francisco, CA.

More from Hyung Kim

1:01
Importance and challenges of biomarker research for kidney cancer
Hyung Kim • 18 Feb 2022
0:51
Novel immune therapeutics for adjuvant treatment of kidney cancer
Hyung Kim • 18 Feb 2022
1:08
Clinical trials in adjuvant RCC
Hyung Kim • 18 Feb 2022

Related Videos

4:05
Evaluating triplet therapy in metastatic hormone sensitive prostate cancer
Nick James • 24 Apr 2024
10:42
Management of prostate cancer from the patient perspective
David Matheson • 11 Apr 2024
2:26
Prognostic factors of renal cell cancer in elderly patients
Teemu Murtola • 9 Apr 2024
2:44
The effect of hypoxia on lipid metabolism and prostate cancer tumor growth
Teemu Murtola • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals